Correvio Pharma Corp. Operating Income
Correvio Pharma Corp. reported Operating Income of -$27.45 million for the 12-month period ending 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2020-04-30
| Period end | Operating Income (Loss) 12 month |
|---|---|
| 2019-12-31 | -$27.45M 20-F · filed 2020-04-30 |
| 2018-12-31 | -$26.34M 20-F · filed 2020-04-30 |
| 2017-12-31 | -$22.98M 20-F · filed 2020-04-30 |
| 2016-12-31 | -$14.55M 20-F · filed 2018-04-30 |
| 2015-12-31 | -$22.08M 20-F · filed 2018-04-30 |
| 2014-12-31 | -$16.59M 40-F · filed 2016-03-29 |
| 2013-12-31 | -$16.70M 40-F · filed 2015-03-27 |
| 2012-12-31 | -$25.96M 40-F/A · filed 2014-04-30 |
| 2011-12-31 | -$26.46M 20-F/A · filed 2013-04-18 |
| 2010-12-31 | $36.67M 20-F/A · filed 2013-04-18 |